Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Ho

Showing results (171-180 of 221) with videos related to

Pageof 23
Sort By:
Journal of Virology|January 1, 1995
A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade BJ P Moore, A Trkola, B Korber, et al.
Journal of Virology|November 1, 1995
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgGA Trkola, A B Pomales, H Yuan, et al.
The New England Journal of Medicine|January 3, 1985
Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III)M S Hirsch, G P Wormser, R T Schooley, et al.
Journal of Virology|July 29, 2004
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent mannerJ A McKeating, L Q Zhang, C Logvinoff, et al.
Journal of Virology|November 1, 1994
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biologyF Gao, L Yue, D L Robertson, et al.
The Journal of Clinical Investigation|October 6, 2000
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapyL Zhang, C Chung, B S Hu, et al.
Annals of Neurology|May 1, 1988
Peripheral neuropathy in the acquired immunodeficiency syndromeS M de la Monte, D H Gabuzda, D D Ho, et al.
The Journal of Experimental Medicine|July 22, 1998
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapyL Morris, J M Binley, B A Clas, et al.
Journal of Virology|March 1, 1994
Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitorD D Ho, T Toyoshima, H Mo, et al.
The New England Journal of Medicine|December 12, 1985
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndromeD D Ho, T R Rota, R T Schooley, et al.
Pageof 23

Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Journal of Virology|January 1, 1995
A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade BJ P Moore, A Trkola, B Korber, et al.
Journal of Virology|November 1, 1995
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgGA Trkola, A B Pomales, H Yuan, et al.
The New England Journal of Medicine|January 3, 1985
Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III)M S Hirsch, G P Wormser, R T Schooley, et al.
Journal of Virology|July 29, 2004
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent mannerJ A McKeating, L Q Zhang, C Logvinoff, et al.
Journal of Virology|November 1, 1994
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biologyF Gao, L Yue, D L Robertson, et al.
The Journal of Clinical Investigation|October 6, 2000
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapyL Zhang, C Chung, B S Hu, et al.
Annals of Neurology|May 1, 1988
Peripheral neuropathy in the acquired immunodeficiency syndromeS M de la Monte, D H Gabuzda, D D Ho, et al.
The Journal of Experimental Medicine|July 22, 1998
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapyL Morris, J M Binley, B A Clas, et al.
Journal of Virology|March 1, 1994
Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitorD D Ho, T Toyoshima, H Mo, et al.
The New England Journal of Medicine|December 12, 1985
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndromeD D Ho, T R Rota, R T Schooley, et al.
Pageof 23